Accelerated access to innovative medicines for patients in need

L. G. Baird, R. Banken, H. G. Eichler, F. B. Kristensen, D. K. Lee, J. C W Lim, R. Lim, C. Longson, E. Pezalla, T. Salmonson, D. Samaha, S. Tunis, J. Woodcock, G. Hirsch

Research output: Contribution to journalArticle

Abstract

There is broad agreement among health-care stakeholders that more must be done to ensure that patients have timely access to new and innovative medicines. Assuming that industry will continue to develop such medicines at a sustainable rate, regulators and payers become the gatekeepers. Regulators, starting in the late 1980s/early 1990s, and, more recently, payers have implemented a variety of early-access pathways or initiatives, and this practice is continuing even today. This article describes the specific approaches that have been taken in four economically developed regions, reviews their success rates, and suggests possible new directions.

Original languageEnglish (US)
Pages (from-to)559-571
Number of pages13
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number5
DOIs
StatePublished - Aug 13 2014
Externally publishedYes

Fingerprint

Industry
Delivery of Health Care
Direction compound

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Baird, L. G., Banken, R., Eichler, H. G., Kristensen, F. B., Lee, D. K., Lim, J. C. W., ... Hirsch, G. (2014). Accelerated access to innovative medicines for patients in need. Clinical Pharmacology and Therapeutics, 96(5), 559-571. https://doi.org/10.1038/clpt.2014.145

Accelerated access to innovative medicines for patients in need. / Baird, L. G.; Banken, R.; Eichler, H. G.; Kristensen, F. B.; Lee, D. K.; Lim, J. C W; Lim, R.; Longson, C.; Pezalla, E.; Salmonson, T.; Samaha, D.; Tunis, S.; Woodcock, J.; Hirsch, G.

In: Clinical Pharmacology and Therapeutics, Vol. 96, No. 5, 13.08.2014, p. 559-571.

Research output: Contribution to journalArticle

Baird, LG, Banken, R, Eichler, HG, Kristensen, FB, Lee, DK, Lim, JCW, Lim, R, Longson, C, Pezalla, E, Salmonson, T, Samaha, D, Tunis, S, Woodcock, J & Hirsch, G 2014, 'Accelerated access to innovative medicines for patients in need', Clinical Pharmacology and Therapeutics, vol. 96, no. 5, pp. 559-571. https://doi.org/10.1038/clpt.2014.145
Baird LG, Banken R, Eichler HG, Kristensen FB, Lee DK, Lim JCW et al. Accelerated access to innovative medicines for patients in need. Clinical Pharmacology and Therapeutics. 2014 Aug 13;96(5):559-571. https://doi.org/10.1038/clpt.2014.145
Baird, L. G. ; Banken, R. ; Eichler, H. G. ; Kristensen, F. B. ; Lee, D. K. ; Lim, J. C W ; Lim, R. ; Longson, C. ; Pezalla, E. ; Salmonson, T. ; Samaha, D. ; Tunis, S. ; Woodcock, J. ; Hirsch, G. / Accelerated access to innovative medicines for patients in need. In: Clinical Pharmacology and Therapeutics. 2014 ; Vol. 96, No. 5. pp. 559-571.
@article{782d9d5f8b1f476fa1b3aa46344a22fc,
title = "Accelerated access to innovative medicines for patients in need",
abstract = "There is broad agreement among health-care stakeholders that more must be done to ensure that patients have timely access to new and innovative medicines. Assuming that industry will continue to develop such medicines at a sustainable rate, regulators and payers become the gatekeepers. Regulators, starting in the late 1980s/early 1990s, and, more recently, payers have implemented a variety of early-access pathways or initiatives, and this practice is continuing even today. This article describes the specific approaches that have been taken in four economically developed regions, reviews their success rates, and suggests possible new directions.",
author = "Baird, {L. G.} and R. Banken and Eichler, {H. G.} and Kristensen, {F. B.} and Lee, {D. K.} and Lim, {J. C W} and R. Lim and C. Longson and E. Pezalla and T. Salmonson and D. Samaha and S. Tunis and J. Woodcock and G. Hirsch",
year = "2014",
month = "8",
day = "13",
doi = "10.1038/clpt.2014.145",
language = "English (US)",
volume = "96",
pages = "559--571",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Accelerated access to innovative medicines for patients in need

AU - Baird, L. G.

AU - Banken, R.

AU - Eichler, H. G.

AU - Kristensen, F. B.

AU - Lee, D. K.

AU - Lim, J. C W

AU - Lim, R.

AU - Longson, C.

AU - Pezalla, E.

AU - Salmonson, T.

AU - Samaha, D.

AU - Tunis, S.

AU - Woodcock, J.

AU - Hirsch, G.

PY - 2014/8/13

Y1 - 2014/8/13

N2 - There is broad agreement among health-care stakeholders that more must be done to ensure that patients have timely access to new and innovative medicines. Assuming that industry will continue to develop such medicines at a sustainable rate, regulators and payers become the gatekeepers. Regulators, starting in the late 1980s/early 1990s, and, more recently, payers have implemented a variety of early-access pathways or initiatives, and this practice is continuing even today. This article describes the specific approaches that have been taken in four economically developed regions, reviews their success rates, and suggests possible new directions.

AB - There is broad agreement among health-care stakeholders that more must be done to ensure that patients have timely access to new and innovative medicines. Assuming that industry will continue to develop such medicines at a sustainable rate, regulators and payers become the gatekeepers. Regulators, starting in the late 1980s/early 1990s, and, more recently, payers have implemented a variety of early-access pathways or initiatives, and this practice is continuing even today. This article describes the specific approaches that have been taken in four economically developed regions, reviews their success rates, and suggests possible new directions.

UR - http://www.scopus.com/inward/record.url?scp=84908203910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908203910&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.145

DO - 10.1038/clpt.2014.145

M3 - Article

C2 - 25006877

AN - SCOPUS:84908203910

VL - 96

SP - 559

EP - 571

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -